12.05.12
Evolva Holding SA, Reinach, Switzerland, has entered an agreement to acquire certain assets owned by Fluxome Sciences A/S, a private Danish company that is in reconstruction. The agreement is subject to creditor and court approval, which was anticipated to occur by early December. The transaction is not expected to change Evolva’s 2012 financial projections. Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. The company uses biosynthetic and evolutionary technologies to create and optimize small molecule compounds and their production routes.
In related news, Fluxome Inc. has unveiled a new name, logo and marketing strategy for its natural resveratrol. Under the rebranded name PureVera, the company’s objective is to position its product as the leading resveratrol source in the nutraceuticals market. PureVera resveratrol is a 98% pure trans-resveratrol that is naturally produced by a patented, eco-friendly fermentation process. In addition, it is U.S. GRAS-affirmed and European Novel Foods approved.
In related news, Fluxome Inc. has unveiled a new name, logo and marketing strategy for its natural resveratrol. Under the rebranded name PureVera, the company’s objective is to position its product as the leading resveratrol source in the nutraceuticals market. PureVera resveratrol is a 98% pure trans-resveratrol that is naturally produced by a patented, eco-friendly fermentation process. In addition, it is U.S. GRAS-affirmed and European Novel Foods approved.